Staphylococcus aureus carrier of oxacillin-sensitive mecA gene (OS-MRSA):
another challenge for microbiology laboratories
Abstract
Staphylococcus aureusis a common human pathogen that is able to acquire resistance mechanisms for different antibiotics. Oxaxicillin resistance mainly results from mecA or mecC genes which determine an oxacillin minimum inhibitory concentration (MIC) ³4 mg/L. Expression of these genes is variable and the isolation of mecA gen with oxacillin MIC ³2 mg/L (phenotypically susceptible) have been described carriers has been described, having been named OS-MRSA. S. aureus bacteria was isolated from the synovial fluid and blood culture in a girl with a joint infection. Isolation of the blood culture was classified as methicillin resistant (MRSA) while thet of the synovial fluid was methicillin sensitive (MSSA), by using the automatized Vitek 2 system. Both of them present oxacillin inhibition halos > 15 mm, and inhibition halos of 19 and 17 mm for cefoxitin, respectively. Both isolations proved mecA, sea, seb and type V SCCmec genes were present. Genetic comparison by SmaI-PFGE showed identical profiles for both cultures, suggesting it was the same strain. These report informs the identification of an OS-MRSA isolation in Uruguay and points out the limitation of a few laboratory procedures to correctly identify resistant phenotypes associated to mecA gene in clinical isolations of S. aureus.
References
(1) Clinical and Laboratory Standards Institute. M100 performance standards for antimicrobial susceptibility testing. 28 ed. Wayne, PA: CLSI, 2018.
(2) Pardo L, Vola M, Macedo-Viñas M, Machado V, Cuello D, Mollerach M, et al. Community-associated methicillin-resistant Staphylococcus aureus in children treated in Uruguay. J Infect Dev Ctries 2013; 7(1):10-6.
(3) Kondo Y, Ito T, Ma X, Watanabe S, Kreiswirth B, Etienne J, et al. Combination of multiplex PCRs for staphylococcal cassette chromosome mec type assignment: rapid identification system for mec, ccr, and major differences in junkyard regions. Antimicrob Agents Chemother 2007; 51(1):264-74.
(4) Mehrotra M, Wang G, Johnson W. Multiplex PCR for detection of genes for Staphylococcus aureus enterotoxins, exfoliative toxins, toxic shock syndrome toxin 1, and methicillin resistance. J Clin Microbiol 2000; 38(3):1032-5.
(5) International Working Group on the Staphylococcal Cassette Chromosome Elements. IWG-SCC Home. 2012 Disponible en: http://www.sccmec.org/Pages/SCC_HomeEN.html. (Consulta: 4 abril 2018).
(6) Hososaka Y, Hanaki H, Endo H, Suzuki Y, Nagasawa Z, Otsuka Y, et al. Characterization of oxacillin-susceptible mecA-positive Staphylococcus aureus: a new type of MRSA. J Infect Chemother 2007; 13(2):79-86.
(7) Saeed K, Ahmad N, Dryden M, Cortes N, Marsh P, Sitjar A, et al. Oxacillin-susceptible methicillin-resistant Staphylococcus aureus (OS-MRSA), a hidden resistant mechanism among clinically significant isolates in the Wessex region/UK. Infection 2014; 42(5):843-7.
(8) He W, Chen H, Zhao C, Zhang F, Wang H. Prevalence and molecular typing of oxacillin-susceptible mecA-positive Staphylococcus aureus from multiple hospitals in China. Diagn Microbiol Infect Dis 2013; 77(3):267-9.
(9) Andrade-Figueiredo M, Leal-Balbino T. Clonal diversity and epidemiological characteristics of Staphylococcus aureus: high prevalence of oxacillin-susceptible mecA-positive Staphylococcus aureus (OS-MRSA) associated with clinical isolates in Brazil. BMC Microbiol 2016; 16(1):115.
(10) Sharff K, Monecke S, Slaughter S, Forrest G, Pfieffer C, Ehricht R, et al. Genotypic resistance testing creates new treatment challenges: two cases of oxacillin-susceptible methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2012; 50(12):4151-3.
(11) Chung M, Kim CK, Conceição T, Aires-De-Sousa M, De Lencastre H, Tomasz A. Heterogeneous oxacillin-resistant phenotypes and production of PBP2A by oxacillin-susceptible/mecA-positive MRSA strains from Africa. J Antimicrob Chemother 2016; 71(10):2804-9.
(12) Proulx M, Palace S, Gandra S, Torres B, Weir S, Stiles T, et al. Reversion from methicillin susceptibility to methicillin resistance in staphylococcus aureus during treatment of bacteremia. J Infect Dis 2016; 213(6):1041-8.
(13) Ikonomidis A, Michail G, Vasdeki A, Labrou M, Karavasilis V, Stathopoulos C, et al. In vitro and in vivo evaluations of oxacillin efficiency against mecA-positive oxacillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 2008; 52(11):3905-8.
(14) Saeed K, Marsh P, Ahmad N. Cryptic resistance in Staphylococcus aureus: a risk for the treatment of skin infection? Curr Opin Infect Dis 2014; 27(2):130-6.
(15) Paterson G, Harrison E, Holmes M. The emergence of mecC methicillin-resistant Staphylococcus aureus. Trends Microbiol 2014; 22(1):42-7.
